These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

738 related items for PubMed ID: 9393756

  • 1. T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes.
    Cole DJ, Wilson MC, Rivoltini L, Custer M, Nishimura MI.
    Cancer Res; 1997 Dec 01; 57(23):5320-7. PubMed ID: 9393756
    [Abstract] [Full Text] [Related]

  • 2. Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1.
    Rivoltini L, Kawakami Y, Sakaguchi K, Southwood S, Sette A, Robbins PF, Marincola FM, Salgaller ML, Yannelli JR, Appella E.
    J Immunol; 1995 Mar 01; 154(5):2257-65. PubMed ID: 7868898
    [Abstract] [Full Text] [Related]

  • 3. Identification of MART-1-specific T-cell receptors: T cells utilizing distinct T-cell receptor variable and joining regions recognize the same tumor epitope.
    Cole DJ, Weil DP, Shamamian P, Rivoltini L, Kawakami Y, Topalian S, Jennings C, Eliyahu S, Rosenberg SA, Nishimura MI.
    Cancer Res; 1994 Oct 15; 54(20):5265-8. PubMed ID: 7522957
    [Abstract] [Full Text] [Related]

  • 4. Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition.
    Stevens EJ, Jacknin L, Robbins PF, Kawakami Y, el Gamil M, Rosenberg SA, Yannelli JR.
    J Immunol; 1995 Jan 15; 154(2):762-71. PubMed ID: 7814882
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The T-cell receptor V beta gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma.
    Weidmann E, Whiteside TL, Giorda R, Herberman RB, Trucco M.
    Cancer Res; 1992 Nov 01; 52(21):5913-20. PubMed ID: 1382847
    [Abstract] [Full Text] [Related]

  • 8. MAGE-1-specific precursor cytotoxic T-lymphocytes present among tumor-infiltrating lymphocytes from a patient with breast cancer: characterization and antigen-specific activation.
    Toso JF, Oei C, Oshidari F, Tartaglia J, Paoletti E, Lyerly HK, Talib S, Weinhold KJ.
    Cancer Res; 1996 Jan 01; 56(1):16-20. PubMed ID: 8548758
    [Abstract] [Full Text] [Related]

  • 9. Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity.
    Clay TM, Custer MC, Sachs J, Hwu P, Rosenberg SA, Nishimura MI.
    J Immunol; 1999 Jul 01; 163(1):507-13. PubMed ID: 10384155
    [Abstract] [Full Text] [Related]

  • 10. Human renal cell carcinoma antigen-specific CTLs: antigen-driven selection and long-term persistence in vivo.
    Jantzer P, Schendel DJ.
    Cancer Res; 1998 Jul 15; 58(14):3078-86. PubMed ID: 9679974
    [Abstract] [Full Text] [Related]

  • 11. Evidence for oligoclonal T-cell response in a metastasis of renal cell carcinoma responding to vaccination with autologous tumor cells and transfer of in vitro-sensitized vaccine-draining lymph node lymphocytes.
    Weidmann E, Logan TF, Yasumura S, Kirkwood JM, Trucco M, Whiteside TL.
    Cancer Res; 1993 Oct 15; 53(20):4745-9. PubMed ID: 8402652
    [Abstract] [Full Text] [Related]

  • 12. Suboptimal activation of CD8(+) T cells by melanoma-derived altered peptide ligands: role of Melan-A/MART-1 optimized analogues.
    Carrabba MG, Castelli C, Maeurer MJ, Squarcina P, Cova A, Pilla L, Renkvist N, Parmiani G, Rivoltini L.
    Cancer Res; 2003 Apr 01; 63(7):1560-7. PubMed ID: 12670905
    [Abstract] [Full Text] [Related]

  • 13. Analysis of T cell receptor alpha beta variability in tumor-infiltrating lymphocytes in primary and metastatic melanoma.
    Zeuthen J, Birck A, Straten PT.
    Arch Immunol Ther Exp (Warsz); 1995 Apr 01; 43(2):123-33. PubMed ID: 8744727
    [Abstract] [Full Text] [Related]

  • 14. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
    Maeurer MJ, Martin D, Elder E, Storkus WJ, Lotze MT.
    Clin Cancer Res; 1996 Jan 01; 2(1):87-95. PubMed ID: 9816095
    [Abstract] [Full Text] [Related]

  • 15. Shared amino acid sequences in the ND beta N and N alpha regions of the T cell receptors of tumor-infiltrating lymphocytes within malignant glioma.
    Ebato M, Nitta T, Yagita H, Sato K, Okumura K.
    Eur J Immunol; 1994 Dec 01; 24(12):2987-92. PubMed ID: 7805726
    [Abstract] [Full Text] [Related]

  • 16. Fine structural variations of alphabetaTCRs selected by vaccination with natural versus altered self-antigen in melanoma patients.
    Wieckowski S, Baumgaertner P, Corthesy P, Voelter V, Romero P, Speiser DE, Rufer N.
    J Immunol; 2009 Oct 15; 183(8):5397-406. PubMed ID: 19786555
    [Abstract] [Full Text] [Related]

  • 17. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
    Sensi M, Salvi S, Castelli C, Maccalli C, Mazzocchi A, Mortarini R, Nicolini G, Herlyn M, Parmiani G, Anichini A.
    J Exp Med; 1993 Oct 01; 178(4):1231-46. PubMed ID: 8376931
    [Abstract] [Full Text] [Related]

  • 18. Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues.
    Parkhurst MR, Salgaller ML, Southwood S, Robbins PF, Sette A, Rosenberg SA, Kawakami Y.
    J Immunol; 1996 Sep 15; 157(6):2539-48. PubMed ID: 8805655
    [Abstract] [Full Text] [Related]

  • 19. Effector T cell analysis of melanoma tumor-infiltrating lymphocyte cultures using HLA-ABC semimatched melanoma cell lines.
    Carlsson B, Sadeghi A, Bengtsson M, Wagenius G, Tötterman TH.
    J Immunother; 2008 Sep 15; 31(7):633-43. PubMed ID: 18600181
    [Abstract] [Full Text] [Related]

  • 20. Selective lysis of autologous tumor cells by recurrent gamma delta tumor-infiltrating lymphocytes from renal carcinoma.
    Choudhary A, Davodeau F, Moreau A, Peyrat MA, Bonneville M, Jotereau F.
    J Immunol; 1995 Apr 15; 154(8):3932-40. PubMed ID: 7706731
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.